Skip to content

To compare 2 drugs: Hyperbaric Ropivacine (0.75%) and Hyperbaric Ropivacine (0.75%) with Fentanyl being injected into the spinal area among patients undergoing lower abdominal surgeries.

COMPARTIVE STUDY OF INTRATHECAL HYPERBARIC ROPIVACINE (0.75 PERCENTAGE) AND HYPERBARIC ROPIVACAINE (0.75 PERCENTAGE) WITH FENTANYL IN PATIENTS UNDERGOING LOWER ABDOMINAL PROCEDURES UNDER SUBARACHANOID BLOCK : A PROSPECTIVE DOUBLE BLIND STUDY. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098953
Enrollment
60
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: INTRATHECAL HYPERBARIC ROPIVACAINE 0.75% + FENTANYL: SUBARACHANOID BLOCK USING 3 ML OF HYPERBARIC ROPIVACAINE (0.75%)COMBINED WITH 0.5 ML FENTANYL AS AN ADJUVANT. FENTANYL ENHANCES THE

Sponsors

CHETTINAD HOSPITAL AND RESEARCH INSTITUTE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American society of Anesthesiologist(ASA) grade I-II. 2. Elective and Emergency lower abdominal surgeries.

Exclusion criteria

Exclusion criteria: 1. Patient refusal 2. History of allergic to study drugs 3. Post spinal surgeries, Spinal deformities, Skin sepsis in lumbar.

Design outcomes

Primary

MeasureTime frame
1. To compare onset and duration of sensory and motor blockade 2. To access the duration of analgesiaTimepoint: First 220 minutes

Secondary

MeasureTime frame
1. To assess and compare the haemodynamic parameters between both groups. 2. To assess the adverse effect of the drug. Timepoint: First 220 minutes

Countries

India

Contacts

Public ContactDr Manimozhi M

Chettinad Hospital and Research Institute

coolajaypareek@yahoo.com9411580475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026